Phase 3 Crohn's Disease and Colitis Trial, By Invitation NCT07154784 Sponsor: Seoul National University Hospital Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 3 Crohn's Disease and Colitis Trial, By Invitation

NCT07154784
By Invitation Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 10 and 80 years old.
  • People who have had a diagnosis of ulcerative colitis for at least 3 months.
  • People with mild to moderate ulcerative colitis, measured by a specific scoring system (called the Mayo score) falling within a defined range (confirm with trial site if unsure about your score).
  • People whose ulcerative colitis affects the rectum, with inflammation extending at least 5 cm, confirmed by a camera examination of the bowel.
  • People who are willing to sign a written consent form agreeing to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been hospitalised due to a very severe flare of ulcerative colitis (the most serious category on the Mayo scoring scale).
  • People with a very low level of a type of white blood cell called neutrophils (a condition known as neutropenia).
  • People who are pregnant.
  • People whose bowel inflammation is caused by an infection other than a specific bacteria called Clostridioides difficile.
  • People who have had their colon surgically removed (note: removal of the appendix alone does not apply here).
  • People who have used antibiotics in the past 2 weeks.
  • People who have used steroid medications above a certain dose in the past 4 weeks.
  • People who are currently using or planning to use certain advanced medications that target the immune system, such as biologic therapies or JAK inhibitors (confirm with trial site for the full list of affected medications).
  • People who have a significant food allergy.
  • People whose bowel disease cannot be clearly classified as either ulcerative colitis or Crohn's disease (sometimes called indeterminate colitis).
  • People who have certain serious long-term health conditions, including chronic liver disease, heart failure, or a chronic lung condition called COPD.
  • People who do not wish to participate in the study.
  • People considered unsuitable for the trial for any other reason, as determined by the treating investigator.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
19 July 2023
Est. completion
19 July 2023

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Co-primary outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov